Acadian Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $23K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25K | Sell |
|
|||||
|
2023
Q3 | $145K | Sell |
|
|||||
|
2023
Q2 | $625K | Hold |
|
|||||
|
2023
Q1 | $402K | Hold |
|
|||||
|
2022
Q4 | $625K | Buy |
|
|||||
|
2022
Q3 | $245K | Buy |
|
|||||
|
2022
Q2 | $208K | Buy |
|
|||||
|
2022
Q1 | $342K | Buy |
|
|||||
|
2021
Q4 | $620K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $69K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $519K | Sell |
|
|||||
|
2018
Q2 | $773K | Buy |
|
|||||
|
2018
Q1 | $307K | Buy |
|
|||||
|
2017
Q4 | $54K | Buy |
|
|||||
|
2017
Q3 | $22K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $2K | Buy |
|